The American Heart Association's Get with the Guidelines (GWTG)-Stroke development and impact on stroke care

Stroke and Vascular Neurology

Volumn 2, Issue 2, 2017, Pages 94-105

  Ormseth, Cora H ^a   Sheth, Kevin N ^a   Saver, Jeffrey L ^b   Fonarow, Gregg C ^b   Schwamm, Lee H ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CONSENSUS; HEALTH CARE QUALITY; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MEDICAL SOCIETY; PRACTICE GUIDELINE; PROGRAM EVALUATION; PROTOCOL COMPLIANCE; TOTAL QUALITY MANAGEMENT; UNITED STATES;

AMERICAN HEART ASSOCIATION; CONSENSUS; DELIVERY OF HEALTH CARE, INTEGRATED; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PROGRAM EVALUATION; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; STROKE; UNITED STATES;

EID: 85048087229     PISSN: 20598688     EISSN: 20598696     Source Type: Journal    
DOI: 10.1136/svn-2017-000092     Document Type: Review

References (130)

1. LaBresh KA, Gliklich R, Liljestrand J, et al. Using "get with the guidelines™ to improve cardiovascular secondary prevention. Jt Comm J Qual Saf 2003;29:539-50.
2. Hong Y, LaBresh KA. Overview of the American Heart Association "Get with the Guidelines™ programs: coronary heart disease, stroke, and heart failure. Crit Pathw Cardiol 2006;5:179-86.
3. Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 2005;45:1147-56.
4. Reeves MJ, Parker C, Fonarow GC, et al. Development of stroke performance measures: definitions, methods, and current measures. Stroke 2010;41:1573-8.
5. Schwamm L, Fayad P, Acker JE. Association to reduce death and disability due to stroke: A presidential advisory from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation. Stroke 2010;41:1051-65.
6. Tissue plasminogen activator for acute ischemic stroke. the National Institute of neurological disorders and stroke rt-PA stroke study group. N Engl J Med 1995;333:1581-7.
7. Kennedy EM, Frist B. Stroke Treatment and Ongoing Prevention Act of 2001: Report Together with Additional Views (to Accompany S. 1274. Washington, D.C: U.S. Government Printing Office, 2001;2:15116-8.
8. Wattigney WA, Croft JB, Mensah GA, et al. Establishing data elements for the Paul Coverdell National Acute Stroke Registry: part 1. Proceedings of an expert panel. Stroke 2003;34:151-6.
9. Reeves MJ, Arora S, Broderick JP, et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005;36:1232-40.
10. LaBresh KA, Tyler PA. A collaborative model for hospital-based cardiovascular secondary prevention. Qual Manag Health Care 2003;12:20-7.
11. Fonarow GC, Gawlinski A, Moughrabi S, et al. Improved treatment of coronary heart disease by implementation of a cardiac hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819-22.
12. LaBresh KA, Ellrodt AG, Gliklich R, et al. Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med 2004;164:203-9.
13. Smaha LA; American Heart Association. The American Heart Association get with the guidelines program. Am Heart J 2004;148:S46-S48.
14. Schwamm L, Reeves MJ, Frankel M. Designing a sustainable national registry for stroke quality improvement. Am J Prev Med 2006;31:S251-S257.
15. Fonarow GC, Reeves MJ, Smith EE, et al. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes 2010;3:291-302.
16. Get with the Guidelines-Stroke: stroke fact sheet. American Heart Association/American Stroke Association 2015.
17. Ellrodt AG, Fonarow GC, Schwamm LH, et al. Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes. Circulation 2013;128:2447-60.
18. Schwamm LH, Fonarow GC, Reeves MJ, et al. Get with the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 2009;119:107-15.
19. Reeves MJ, Fonarow GC, Smith EE, et al. Representativeness of the get with the Guidelines-Stroke Registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke. Stroke 2012;43:44-9.
20. Xian Y, Fonarow GC, Reeves MJ, et al. Data quality in the American Heart Association get with the Guidelines-Stroke (GWTG-Stroke): Results from a National Data Validation Audit. Am Heart J. In Press. 2012;163:392-8.
21. Reeves MJ, Grau-Sepulveda MV, Fonarow GC, et al. Are quality improvements in the get with the guidelines: stroke program related to better care or better data documentation? Circ Cardiovasc Qual Outcomes 2011;4:503-11.
22. LaBresh KA, Reeves MJ, Frankel MR, et al. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines™ program. Arch Intern Med 2008;168:411-7.
23. Stoeckle-Roberts S, Reeves MJ, Jacobs BS, et al. Closing gaps between evidence-based stroke care guidelines and practices with a collaborative quality improvement project. Jt Comm J Qual Patient Saf 2006;32:517-27.
24. Huang PH, Kim CX, Lerman A, et al. Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelines. Clin Cardiol 2012;35:396-403.
25. Lewis WR, Fonarow GC, Grau-Sepulveda MV, et al. Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from get with the Guidelines-Stroke. Am Heart J 2011;162:692-9.
26. Rost NS, Smith EE, Pervez MA, et al. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts primary Stroke Service Program. Circ Cardiovasc Qual Outcomes 2012;5:314-20.
27. Smith EE, Pan W, Olson D, et al. Frequency and determinants of lipid testing in ischemic stroke and transient ischemic attack: findings from get with the Guidelines-Stroke. Stroke 2010;41:232-8.
28. Ovbiagele B, Schwamm LH, Smith EE, et al. Recent Nationwide Trends in Discharge Statin treatment of hospitalized patients with stroke. Stroke 2010;41:1508-13.
29. O'Brien EC, Greiner MA, Xian Y, et al. Clinical effectiveness of statin therapy after Ischemic Stroke: primary results from the Statin Therapeutic area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study. Circulation 2015;132:1404-13.
30. Reeves MJ, Smith EE, Fonarow GC, et al. Variation and trends in the documentation of National Institutes of Health Stroke Scale in GWTG-Stroke Hospitals. Circ Cardiovasc Qual Outcomes 2015;8:S90-S98.
31. Song S, Fonarow GC, Olson DM, et al. Association of get with the Guidelines-Stroke Program Participation and clinical outcomes for Medicare beneficiaries with ischemic stroke. Stroke 2016;47:1294-302.
32. O'Brien EC, Xian Y, Xu H, et al. Hospital variation in home-time after acute ischemic stroke: insights from the PROSPER study (Patient- Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research). Stroke 2016;47:2627-33.
33. Xian Y, O'Brien EC, Fonarow GC, et al. Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: implementing the patient-driven research paradigm to aid decision making in stroke care. Am Heart J 2015;170:36-45.
34. Bushnell C, Zimmer L, Schwamm L, et al. The adherence eValuation after Ischemic Stroke Longitudinal (AVAIL) Registry: design, rationale, and baseline patient characteristics. Am Heart J 2009;157:428-35.
35. Bettger JP, Thomas L, Liang L, et al. Hospital variation in Functional Recovery after Stroke. Circulation 2017;10:e002391.
36. Bushnell CD, Olson DM, Zhao X, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 2011;77:1182-90.
37. El Husseini N, Goldstein LB, Peterson ED, et al. Depression and antidepressant use after Stroke and transient ischemic attack. Stroke 2012;43:1609-16.
38. Fonarow GC, Liang L, Thomas L, et al. Assessment of hometime after acute ischemic stroke in Medicare beneficiaries. Stroke 2016;47:836-42.
39. Xian Y, Wu J, O'Brien EC, et al. Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study. BMJ 2015;351:h3786.
40. Olson DM, Cox M, Pan W, et al. Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic strokelongitudinal registry. J Stroke Cerebrovasc Dis 2013;22:e181-e188.
41. Lopes RD, Shah BR, Olson DM, et al. Antithrombotic therapy use at Discharge and 1 year in patients with Atrial Fibrillation and acute stroke. Stroke 2011;42:3477-83.
42. Schwamm LH, et al. Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation 2005;111:1078-91.
43. Silva GS, Schwamm LH. Review of stroke center effectiveness and other get with the guidelines data. Curr Atheroscler Rep 2013;15:350.
44. Stroke facility designation and stroke registries. American Heart Association/American Stroke Association 2016.
45. Fonarow GC, Liang L, Smith EE, et al. Comparison of performance achievement award recognition with primary stroke center certification for acute ischemic stroke care. J Am Heart Assoc 2013;2:e000451.
46. Man S, Cox M, Patel P, et al. Differences in acute ischemic Stroke Quality of Care and outcomes by primary Stroke Center Certification Organization. Stroke 2017;48:412-9.
47. del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the Time Window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a Science Advisory from the american Heart Association/American Stroke Association. Stroke 2009;40:2945-8.
48. Messé SR, Fonarow GC, Smith EE, et al. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in get with the Guidelines-Stroke. Circ Cardiovasc Qual Outcomes 2012;5:321-6.
49. Menon BK, Frankel MR, Liang L, et al. Rapid Change in Prescribing Behavior in Hospitals participating in get with the Guidelines- Stroke after Release of the management of Atherothrombosis with Clopidogrel in High-Risk patients (MATCH) Clinical Trial results. Stroke 2010;41:2094-7.
50. Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 2011;123:750-8.
51. Tong D, Reeves MJ, Hernandez AF, et al. Times from Symptom Onset to Hospital Arrival in the get with the Guidelines-Stroke Program 2002 to 2009: temporal trends and implications. Stroke 2012;43:1912-7.
52. Rost NS, Masrur S, Pervez MA, et al. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology 2009;73:1957-62.
53. Saver JL, Smith EE, Fonarow GC, et al. The "Golden Hour™ and Acute Brain Ischemia: Presenting Features and Lytic Therapy in >30 000 Patients Arriving Within 60 Minutes of Stroke Onset. Stroke 2010;41:1431-9.
54. Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013;309:2480-8.
55. Xian Y, Liang L, Smith EE, et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 2012;307:2600-8.
56. Desai JA, Smith EE. Prenotification and other factors involved in rapid tPA administration. Curr Atheroscler Rep 2013;15:337.
57. Lin CB, Cox M, Olson DM, et al. Perception Versus Actual Performance in Timely tissue plasminogen activation administration in the management of acute ischemic stroke. J Am Heart Assoc 2015;4:e001298.
58. Kim JT, Fonarow GC, Smith EE, et al. Treatment with tPA in the "golden hour™ and the shape of the 4.5 hour time-benefit curve in the national US Get With the Guidelines-Stroke population. Circulation 2017;135:128-39.
59. Kelly AG, Hellkamp AS, Olson D, et al. Predictors of rapid brain Imaging in acute Stroke: analysis of the get with the Guidelines- Stroke Program. Stroke 2012;43:1279-84.
60. Olson DM, Constable M, Britz GW, et al. A qualitative assessment of practices associated with shorter door-to-needle time for thrombolytic therapy in acute ischemic stroke. J Neurosci Nurs 2011;43:329-36.
61. Xian Y, Smith EE, Zhao X, et al. Strategies used by hospitals to improve speed of Tissue-Type Plasminogen activator treatment in acute ischemic stroke. Stroke 2014;45:1387-95.
62. Zanichkowsky R, Nascimento JA, McCune M, et al. Where does the Time go? the effect of protocols for Stroke last known well documentation on intravenous recombinant tissue plasminogen activator delivery in the Northeast. J Neurosci Nurs 2016;48:71-4.
63. Bershad EM, Rao CP, Vuong KD, et al. Multidisciplinary protocol for rapid head computed tomography turnaround time in acute stroke patients. J Stroke Cerebrovasc Dis 2015;24:1256-61.
64. Olson DM, Cox M, Constable M, et al. Development and initial testing of the stroke rapid-treatment readiness tool. J Neurosci Nurs 2014;46:267-73.
65. Fonarow GC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014;311:1632-40.
66. Schwamm LH, Ali SF, Reeves MJ, et al. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes 2013;6:543-9.
67. Messé SR, Khatri P, Reeves MJ, et al. Why are acute ischemic stroke patients not receiving IV tPA? results from a national registry. Neurology 2016;87:1565-74.
68. Birnbaum LA, Rodriguez JS, Topel CH, et al. Older Stroke patients with High Stroke scores have delayed Door-To-Needle Times. J Stroke Cerebrovasc Dis 2016;25:2668-72.
69. Arora R, Salamon E, Katz JM, et al. Use and outcomes of intravenous thrombolysis for acute ischemic stroke in patients ≥90 years of Age. Stroke 2016;47:2347-54.
70. Ali SF, Siddiqui K, Ay H, et al. Baseline predictors of Poor Outcome in Patients Too good to treat with intravenous thrombolysis. Stroke 2016;47:2986-92.
71. Smith EE, Fonarow GC, Reeves MJ, et al. Outcomes in mild or rapidly improving Stroke not treated with intravenous recombinant Tissue-Type plasminogen activator: findings from get with the Guidelines-Stroke. Stroke 2011;42:3110-5.
72. Kamal N, Sheng S, Xian Y, et al. Delays in Door-to-Needle Times and their impact on treatment time and outcomes in get with the Guidelines-Stroke. Stroke 2017;48:946-54.
73. Xian Y, Xu H, Lytle B, et al. Use of strategies to improve Door-to- Needle Times with Tissue-Type Plasminogen activator in acute ischemic stroke in clinical practice. Circulation 2017;10:e003227.
74. Cronin CA, Sheth KN, Zhao X, et al. Adherence to third european Cooperative acute Stroke Study 3- to 4.5-hour exclusions and association with outcome: data from get with the Guidelines-Stroke. Stroke 2014;45:2745-9.
75. Giurgiutiu DV, Yoo AJ, Fitzpatrick K, et al. Severity of Leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic stroke. J Neurointerv Surg 2015;7:326-30.
76. Masrur S, Abdullah AR, Smith EE, et al. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. J Stroke Cerebrovasc Dis 2011;20:124-30.
77. Busl KM, Nogueira RG, Yoo AJ, et al. Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients. J Stroke Cerebrovasc Dis 2013;22:718-24.
78. Masrur S, Cox M, Bhatt DL, et al. Association of acute and chronic hyperglycemia with acute ischemic stroke outcomes Post- Thrombolysis: findings from get with the Guidelines-Stroke. J Am Heart Assoc 2015;4:e002193.
79. Romano JG, Smith EE, Liang L, et al. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the get with the Guidelines-Stroke registry. JAMA Neurol 2015;72:423-31.
80. Romano JG, Smith EE, Liang L, et al. Distinct Short-Term Outcomes in Patients with Mild Versus rapidly improving Stroke not treated with thrombolytics. Stroke 2016;47:1278-85.
81. Adams RJ, Cox M, Ozark SD, et al. Coexistent sickle cell disease has no impact on the safety or outcome of lytic therapy in acute ischemic stroke: findings from get with the Guidelines-Stroke. Stroke 2017;48:686-91.
82. Xian Y, Federspiel JJ, Hernandez AF, et al. Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic Stroke who take Non-Vitamin K antagonist oral Anticoagulants before Stroke. Circulation 2017;135:1024-35.
83. Sheth KN, Smith EE, Grau-Sepulveda MV, et al. Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes. Stroke 2015;46:732-9.
84. Pervez MA, Silva G, Masrur S, et al. Remote Supervision of IV-tPA for acute ischemic stroke by Telemedicine or Telephone before transfer to a Regional Stroke Center is feasible and safe. Stroke 2010;41:e18-e24.
85. Ali SF, Singhal AB, Viswanathan A, et al. Characteristics and outcomes among patients transferred to a Regional Comprehensive Stroke Center for Tertiary Care. Stroke 2013;44:3148-53.
86. Milne MS, Holodinsky JK, Hill MD, et al. Drip 'n ship versus mothership for endovascular treatment: modeling the best transportation options for optimal outcomes. Stroke 2017;48:791-4.
87. Smith EE, Shobha N, Dai D, et al. Risk score for in-hospital ischemic stroke mortality derived and validated within the get with the Guidelines-Stroke Program. Circulation 2010;122:1496-504.
88. Menon BK, Saver JL, Prabhakaran S, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous Tissue-Type plasminogen activator. Stroke 2012;43:2293-9.
89. Fonarow GC, Pan W, Saver JL, et al. Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA 2012;308:257-64.
90. Smith EE, Shobha N, Dai D, et al. A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke. J Am Heart Assoc 2013;2:e005207.
91. Fonarow GC, Saver JL, Smith EE, et al. Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J Am Heart Assoc 2012;1:42-50.
92. Brandler ES, Sharma M, McCullough F, et al. Prehospital Stroke identification: factors associated with diagnostic accuracy. J Stroke Cerebrovasc Dis 2015;24:2161-6.
93. Ekundayo OJ, Saver JL, Fonarow GC, et al. Patterns of emergency medical services use and its association with timely stroke treatment: findings from get with the Guidelines-Stroke. Circ Cardiovasc Qual Outcomes 2013;6:262-9.
94. Lin CB, Peterson ED, Smith EE, et al. Patterns, predictors, variations, and temporal trends in emergency medical service hospital prenotification for acute ischemic stroke. J Am Heart Assoc 2012;1:e002345x.
95. Sequeira D, Martin-Gill C, Kesinger MR, et al. Characterizing strokes and stroke mimics transported by helicopter emergency medical services. Prehospital Emergency Care: Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2016:1-6.
96. Sharma M, Helzner E, Sinert R, et al. Patient characteristics affecting stroke identification by emergency medical service providers in Brooklyn, New York. Intern Emerg Med 2016;11:229-36.
97. Studnek JR, Asimos A, Dodds J, et al. Assessing the validity of the Cincinnati prehospital stroke scale and the medic prehospital assessment for code stroke in an urban emergency medical services agency. Prehosp Emerg Care 2013;17:348-53.
98. Menon BK, Saver JL, Goyal M, et al. Trends in endovascular therapy and clinical outcomes within the Nationwide get with the Guidelines-Stroke Registry. Stroke 2015;46:989-95.
99. Stecker M, Michel K, Antaky K, et al. Risk factors for DVT/PE in patients with stroke and intracranial hemorrhage. Open Neurol J 2014;8:1-6.
100. Douds GL, Hellkamp AS, Olson DM, et al. Venous thromboembolism in the get with the Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis. J Stroke Cerebrovasc Dis 2014;23:123-9.
101. Masrur S, Smith EE, Saver JL, et al. Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from get with the guidelines-stroke. J Stroke Cerebrovasc Dis 2013;22:e301-e309.
102. Messe SR, Pervez MA, Smith EE, et al. Lipid Profile, Lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the Guidelines-Stroke. Stroke 2013;44:1354-9.
103. Goldstein JN, Marrero M, Masrur S, et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol 2010;67:965-9.
104. Lewis WR, Fonarow GC, LaBresh KA, et al. Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. Am J Cardiol 2009;103:227-31.
105. Patel PA, Zhao X, Fonarow GC, et al. Novel oral anticoagulant use among patients with Atrial Fibrillation hospitalized with ischemic stroke or transient ischemic attack. Circ Cardiovasc Qual Outcomes 2015;8:383-92.
106. Saposnik G, Fonarow GC, Pan W, et al. Guideline-directed lowdensity lipoprotein management in high-risk patients with ischemic stroke: findings from get with the Guidelines-Stroke 2003 to 2012. Stroke 2014;45:3343-51.
107. Schwamm LH, Reeves MJ, Pan W, et al. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation 2010;121:1492-501.
108. Reeves MJ, Fonarow GC, Zhao X, et al. Quality of Care in Women with ischemic stroke in the GWTG Program. Stroke 2009;40:1127-33.
109. Xian Y, Holloway RG, Smith EE, et al. Racial/Ethnic differences in process of Care and Outcomes among Patients hospitalized with intracerebral hemorrhage. Stroke 2014;45:3243-50.
110. Fonarow GC, Reeves MJ, Zhao X, et al. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation 2010;121:879-91.
111. James ML, Cox M, Xian Y, et al. Sex and age interactions and differences in outcomes after intracerebral hemorrhage. J Womens Health 2017;26:380-8.
112. James ML, Grau-Sepulveda MV, Olson DM, et al. Insurance status and outcome after intracerebral hemorrhage: findings from get with the Guidelines-stroke. J Stroke Cerebrovasc Dis 2014;23:283-92.
113. Mochari-Greenberger H, Xian Y, Hellkamp AS, et al. Racial/Ethnic and sex differences in Emergency Medical Services Transport among Hospitalized US Stroke Patients: analysis of the National get with the Guidelines-Stroke Registry. J Am Heart Assoc 2015;4:e002099.
114. Asdaghi N, Romano JG, Wang K, et al. Sex disparities in ischemic stroke care: fl-pr CRESD study (Florida-Puerto Rico Collaboration to reduce Stroke disparities). Stroke 2016;47:2618-26.
115. Sacco RL, Gardener H, Wang K, et al. Racial-ethnic disparities in Acute Stroke Care in the Florida-puerto Rico Collaboration to reduce Stroke Disparities Study. J Am Heart Assoc 2017;6:e004073.
116. Medford-Davis LN, Fonarow GC, Bhatt DL, et al. Impact of insurance status on outcomes and use of Rehabilitation Services in acute ischemic stroke: findings from get with the guidelines-stroke. J Am Heart Assoc 2016;5:e004282.
117. Reeves MJ, Smith E, Fonarow G, et al. Off-Hour Admission and In- Hospital Stroke Case Fatality in the get with the Guidelines-Stroke Program. Stroke 2009;40:569-76.
118. Smith EE, Liang L, Hernandez A, et al. Influence of stroke subtype on quality of care in the get with the Guidelines-Stroke Program. Neurology 2009;73:709-16.
119. Fonarow GC, Smith EE, Reeves MJ, et al. Hospital-Level variation in mortality and rehospitalization for Medicare beneficiaries with acute ischemic stroke. Stroke 2011;42:159-66.
120. Allen NB, Kaltenbach L, Goldstein LB, et al. Regional variation in Recommended Treatments for ischemic stroke and TIA: get with the Guidelines-Stroke 2003-2010. Stroke 2012;43:1858-64.
121. O'Brien EC, Zhao X, Fonarow GC, et al. Quality of Care and ischemic stroke risk after hospitalization for transient ischemic attack: findings from get with the Guidelines-Stroke. Circ Cardiovasc Qual Outcomes 2015;8:S117-24.
122. Bangalore S, Schwamm L, Smith EE, et al. Secondary prevention after ischemic stroke or transient ischemic attack. Am J Med 2014;127:728-38.
123. O'Brien EC, Wu J, Zhao X, et al. Healthcare Resource Availability, Quality of Care, and acute ischemic stroke outcomes. J Am Heart Assoc 2017;6:e003813.
124. Berthiaume JT, Tyler PA, Ng-Osorio J, et al. Aligning financial incentives with "Get With The Guidelines™ to improve cardiovascular care. Am J Manag Care 2004;10:501-4.
125. Hsieh FI, Lien LM, Chen ST, et al. Get with the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: get with the Guidelines-Stroke in Taiwan. Circulation 2010;122:1116-23.
126. Wang CJ, Wang CX, Zhang L, et al. Advances in stroke care and research in 2010. Clin Exp Pharmacol Physiol 2011;38:562-9.
127. Li Z, Wang C, Zhao X, et al. Substantial Progress yet Significant Opportunity for Improvement in Stroke Care in China. Stroke 2016;47:2843-9.
128. Wang Y, Cui L, Ji X, et al. The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke 2011;6:355-61.
129. Hao Y, Liu J, Liu J, et al. Rationale and design of the improving care for Cardiovascular Disease in China (CCC) project: a national effort to prompt quality enhancement for acute coronary syndrome. Am Heart J 2016;179:107-15.
130. Salinas J, Sprinkhuizen SM, Ackerson T, et al. An International Standard set of Patient-Centered Outcome measures after Stroke. Stroke 2016;47:180-6.